Weekly HEALEY ALS Platform Trial Webinar

Please join us on Thursday, March 23rd at 5:00 pm EST (4:00 pm CST/2:00 pm PST) for a webinar about the HEALEY ALS Platform Trial. Merit Cudkowicz, MD, MSc and Sabrina Paganoni, MD, PhD will present updates on the Platform Trial and answer questions from the audience. In addition, we will be joined by Jeffrey Rothstein, MD, PhD, Director of the Robert Packard Center for ALS Research at Johns Hopkins.

Jeffrey Rothstein, MD, PhD Dr. Rothstein is the founder and director of the Robert Packard Center for ALS Research. The Packard Center is a collaborative academic organization devoted to understanding the cause of ALS and searching for new targeted therapies. Dr. Rothstein’s work specializes in cellular and molecular neuroscience and the neurobiology of disease.